Insights

Innovative Therapeutic Focus Tangram Therapeutics specializes in computational drug discovery with a focus on RNA interference therapeutics, positioning it as a leader in cutting-edge biotech solutions that can benefit from advanced data management and analytic tools.

Strategic Collaboration Opportunities Recent partnerships with companies like Arcturis Data Limited and iTeos Therapeutics highlight opportunities for joint development projects and data integration services to accelerate drug discovery initiatives.

Funding and Growth Potential With $37 million in funding and a revenue range of 1 to 10 million dollars, there is significant scope for expanding technology infrastructure and sales efforts to support ongoing research and commercialization.

Market Engagement & Visibility Participation in prominent events such as the European Haemophilia Congress indicates an active approach to showcasing innovations, providing opportunities for targeted outreach and strategic partnerships.

Leadership & Talent Development The recent addition of senior executives like a new CFO and board members demonstrates a focus on strengthening leadership, which can facilitate enterprise growth and open avenues for executive-level collaborations.

Tangram Therapeutics Tech Stack

Tangram Therapeutics uses 8 technology products and services including Font Awesome, GitLab, HSTS, and more. Explore Tangram Therapeutics's tech stack below.

  • Font Awesome
    Font Scripts
  • GitLab
    Issue Trackers
  • HSTS
    Security
  • X-XSS-Protection
    Security
  • Google Analytics
    Web Analytics
  • Django
    Web Frameworks
  • Nginx
    Web Servers
  • Apache
    Web Servers

Media & News

Tangram Therapeutics's Email Address Formats

Tangram Therapeutics uses at least 1 format(s):
Tangram Therapeutics Email FormatsExamplePercentage
First.Last@etherapeutics.co.ukJohn.Doe@etherapeutics.co.uk
95%
First-L@etherapeutics.co.ukJohn-D@etherapeutics.co.uk
3%
First@etherapeutics.co.ukJohn@etherapeutics.co.uk
1%
First.Middle@etherapeutics.co.ukJohn.Michael@etherapeutics.co.uk
1%

Frequently Asked Questions

Where is Tangram Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Tangram Therapeutics's main headquarters is located at 4th Floor, 4 Kingdom Street London , W2 6BD, GB. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Tangram Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Tangram Therapeutics's official website is etherapeutics.co.uk and has social profiles on LinkedInCrunchbase.

What is Tangram Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Tangram Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Tangram Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2025, Tangram Therapeutics has approximately 52 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: A. M.Chief Operating And Business Officer: L. R.Chief Scientific Officer: A. W.. Explore Tangram Therapeutics's employee directory with LeadIQ.

What industry does Tangram Therapeutics belong to?

Minus sign iconPlus sign icon
Tangram Therapeutics operates in the Biotechnology Research industry.

What technology does Tangram Therapeutics use?

Minus sign iconPlus sign icon
Tangram Therapeutics's tech stack includes Font AwesomeGitLabHSTSX-XSS-ProtectionGoogle AnalyticsDjangoNginxApache.

What is Tangram Therapeutics's email format?

Minus sign iconPlus sign icon
Tangram Therapeutics's email format typically follows the pattern of First.Last@etherapeutics.co.uk. Find more Tangram Therapeutics email formats with LeadIQ.

How much funding has Tangram Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2025, Tangram Therapeutics has raised $37M in funding. The last funding round occurred on Jul 03, 2024 for $37M.
Tangram Therapeutics

Tangram Therapeutics

Biotechnology ResearchUnited Kingdom51-200 Employees

A specialist in computational drug discovery with a focus on developing RNA interference (“RNAi”) therapeutics

Section iconCompany Overview

Headquarters
4th Floor, 4 Kingdom Street London , W2 6BD, GB
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $37M

    Tangram Therapeutics has raised a total of $37M of funding over 5 rounds. Their latest funding round was raised on Jul 03, 2024 in the amount of $37M.

  • $1M$10M

    Tangram Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $37M

    Tangram Therapeutics has raised a total of $37M of funding over 5 rounds. Their latest funding round was raised on Jul 03, 2024 in the amount of $37M.

  • $1M$10M

    Tangram Therapeutics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.